ABSTRACT
3,4
Traditionally, blood tests and other special investigations such as electrocardiograms (ECGs) and radiologic investigations (plain x-rays) take place after the doctor has clinically evaluated the patient. Patients (and doctors) then have to wait for the results of these tests before a decision can be made regarding the need for further investigations and the patient's final disposition. Point-of-care (POC) testing has been suggested as a throughput intervention to aid in decreasing ED overcrowding.
2,4,5 POC blood testing refers to selected tests that can be performed in the ED at the bedside and provide immediate, on-site results that can potentially expedite patient management decisions. 6 Similarly, low-dose x-ray (LODOX) is the radiologic equivalent of a POC blood test, providing a full body x-ray within 19 seconds. LODOX has been evaluated in trauma patients, but its application as a diagnostic tool for nontrauma patients in the ED has not been investigated previously. 7 While POC tests have been shown to decrease result turnaround times, there has been mixed evidence for their usefulness in the ED. 1, 4, [8] [9] [10] The utility of POC tests has only previously been evaluated when obtained after the patient has interacted with a doctor or nurse. The use of POC tests before a doctor has seen the patient has not been explored before.
The aim of this study was to compare the standard workflow pathway in the ED to a modified, protocolized pathway that made use of upfront POC tests (blood tests, ECG, and/or LODOX) performed prior to doctor evaluation to determine if this could produce a significant reduction in treatment time in the ED.
Materials and Methods

Study Design and Setting
This was an investigator-initiated, prospective, randomized, controlled trial that took place in a tertiary, academic hospital ED in a metropolitan area of Johannesburg, South Africa. The ED sees approximately 65,000 patients annually. Most patients have nontraumatic pathologies (approximately 70%), and the rest are trauma related. Pediatric as well as obstetric and gynecology patients are mainly seen at the nearby sister hospital.
Permission to conduct the study was granted by the Research Ethics Committee of the Faculty of Health Sciences of the University of Johannesburg (REC-01-185-2016), the Human Research Ethics Committee of the University of the Witwatersrand (M171086), and South African National Health Research Ethics Committee (DOH-27-0117-5628), and it was registered as a clinical trial with the South African National Health Research Database (GP_2017RP57_655) as well as with clinicaltrials.gov (NCT03102216). Written informed consent was obtained for all patients. In patients in whom consent could not be obtained (eg, psychiatric patients), consent was obtained from the patient's relative at the time of the patient's presentation to the ED. The patient was then followed up in the ward by the research doctor/research assistant to obtain delayed consent once the patient was competent.
Selection of Participants
All consenting adult patients older than 18 years who had one of the symptom groups below, presented to the ED during weekdays, did not require immediate resuscitation, and were not pregnant were eligible for inclusion in the study.
Presenting symptom groups:
• Abdominal/epigastric/stomach pain/vomiting ("abdominal symptoms")
• Psychosis/aggression/hallucinations/overdose ("psychiatric") • Shortness of breath/dyspnea/cough/chest pain/syncope ("chest symptoms") • Generalized body pain or weakness ("GBP/GBW") Patients were then randomized into one of the 12 workflow pathways ❚Figure 1❚. The block randomization was done prior to study commencement using an online randomization tool (www.randomizer.org). Each data collection sheet set was then placed upside-down in the order generated in an individual symptom box. The research doctor/research assistant took the next data collection sheet in the order supplied, after the patient had signed consent.
To ascertain whether an individual POC test or a certain combination of POC tests provided the most benefit with regard to time saving, patients in each symptom group were randomized to receive either the standard workflow pathway (the control pathway) or one of the enhanced workflow pathways with one, two, three, or four POC tests in various combinations (see Figure 1 ).
In the control workflow pathway, after patients were triaged, they were seen by a doctor. Diagnostic tests and investigations that were clinically indicated were then ordered by the doctor. Diagnostic blood tests were performed in the on-site hospital laboratory according to standard procedures, x-rays were performed in the radiology department, and if the patient required a blood gas analysis to be done, this was performed by the doctor on one of two blood gas analyzers available in the ED (Cobas B 221 POC system [Roche Diagnostics, Basel, Switzerland] or ABL800 Flex [Radiometer, Copenhagen, Denmark]).
Once the results of those tests were ready, the doctor then reviewed the patient a second time with all the results. The decision for patient disposition was then made.
In the enhanced workflow pathways, if the doctor deemed it necessary to perform additional investigations over and above the POC tests, those tests were performed as clinically indicated according to standard procedures. The patient was reviewed once the additional results were available.
Patient throughput time in the ED can be divided into front-end/administrative time (patient time of arrival to doctor evaluation) and treatment time (time from doctor evaluation to disposition). 11 The administrative time consists of opening a file and registering on the hospital system. All patients go through the same process. However, on some days, the administrative process can be substantially longer than on other days. This would change the wait times for the patients prior to them presenting to the doctor and would confound the time measurements overall. To remove the confounders that the administrative time could have had on the utility of POC testing, we assessed only the treatment time in this study.
In each group, treatment time was measured from the time the doctor first saw the patient until the disposition decision was made. The disposition time was chosen rather than the time the patient actually left the ED because exit block or other factors could delay the patients' departure from the ED. This would confound rather than enhance the data.
For the particular symptom groups that were included in the study, patients were not subjected to any form of investigation or testing that they would not most likely have received in any case by following the standard (control) workflow pathway. The only difference for the enhanced workflow groups is that the tests were performed at the POC in the ED prior to the patient seeing the ED doctor for the first time.
Interventions
Abbott Point of Care i-STAT System
The i-STAT system consists of a handheld POC blood analyzer and single-use i-STAT test cartridges (i-STAT; Abbott Point of Care, Princeton, NJ). The CHEM8+ (sodium, potassium, chloride, total carbon dioxide, ionized calcium, glucose, urea, creatinine, hematocrit, hemoglobin, and anion gap) (2 minutes), prothrombin time/ international normalized ratio (2 minutes), CG4+ (lactate, pH, partial pressure carbon dioxide, partial pressure of oxygen, total carbon dioxide, bicarbonate, base excess and oxygen saturation) (2 minutes), and troponin I (10 minutes) i-STAT cartridges were used. These tests were run concurrently.
Quality controls were performed on each batch of cartridges to ensure correct target values, calibration verification, and ranges for the i-STAT cartridges as per the manufacturer's guidelines.
Abbott CEL-DYN Emerald 22 Benchtop Hematology System
The only category of blood investigation not covered by the i-STAT system was with regard to the assessment of infection. To this end, the CEL-DYN Emerald 22 benchtop hematology system (Abbott Diagnostics, Johannesburg, South Africa), which is capable of providing a POC CBC as well as a WBC differential count, was used. Processing time was 90 seconds.
Quality controls were performed daily on this machine as per the manufacturer's guidelines.
ECG
Philips (Amsterdam, the Netherlands) Pagewriter TC30 ECG machines were used to obtain the ECGs, which were obtained according to standard procedures and the equipment used as per the manufacturer's guidelines. A standard 12-lead ECG as well as a right-sided (V1R-V6R) and posterior (V7-V9) ECG were performed on all patients randomized to receive "an ECG."
LODOX
A radiographer performed the LODOX radiographs (chest and abdomen, anteroposterior and lateral) on a LODOX Xmplar-dr (Lodox Systems, Johannesburg, South Africa). The radiation exposure was approximately 339 μGy per patient vs a standard chest and abdomen radiograph of approximately 5,200 μGy.
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Synchronized Clocks
Synchronized clocks are normal time-of-day displaying clocks that are calibrated through satellite GPS that is built into the unit. These units do not require time setting, as they automatically correct their time on a minute-to-minute basis through GPS signal received. These clocks were in all the areas of the ED where times were recorded.
Measurements
The sample size estimation was based on the determination of the effect of workflow pathways within each symptom group. This required a two-way analysis of variance. Based on the detection of at least a medium effect size (f = 0.25 or a 20% difference in times between groups) with 80% power at the 5% significance level, a sample size of 1,116 was required.
The data collection procedure is shown in the flowchart in Figure 1 . All times were recorded by the doctors in the ED on a data collection sheet, which was appended to each patient's file.
All POC testing was performed in a private cubicle within the ED where the LODOX machine was located. All other testing was done as per standard procedure for standard workflow within the ED.
Costs of Investigations
Prices for the control pathway investigations were obtained from the relevant hospital departments. Costs for the POC tests were based on standard ED usage. Capital costs of equipment as well as maintenance were taken as being included in the prices of all tests.
Outcomes
The main outcome measure for this study was treatment time, defined as the time from initial contact between doctor and patient to the time of his or her disposition decision. Previous studies have used statistical significance over clinical significance and shown a reduction in treatment time (or equivalent time saving) ranging from 9% to 18%. 4, 13 We decided that in order for the tests to be considered worthwhile from a time-saving perspective, they would need to demonstrate a clinically meaningful decrease in treatment time. For this reason, we rounded up the time-saving threshold reported in previous studies to 20%. A 20% reduction in treatment time with the enhanced workflow pathways compared with the control pathway was therefore considered clinically significant.
Statistical Analysis
The effect of workflow (within each symptom group) and symptom group (within each workflow) on the outcome (treatment time), controlling for the covariates (time of day of arrival at triage, number of patients seen on that day, number of patients enrolled between 8 am and 4 pm on that day, and triage category), was determined by a general linear model with treatment time as the dependent variable and the independent variables of workflow, symptom group, their interaction, and each of the covariates and their two-way interactions with workflow and symptom group (excluding the two-way interactions with triage category since not all combinations of triage category and [workflow, symptom group] were covered in the study). A log transformation of the dependent variable was used to meet the assumptions of the general linear model. This was due to the right skewness of time data. All two-factor interactions, including that between workflow and symptom group, were removed from the model since they were not significant. Post hoc tests were carried out using the Tukey-Kramer adjustment for multiple comparisons.
The effect of decision (admission/discharge), workflow, and symptom group on treatment time, controlling for the covariates (as above), was also determined by a general linear model. A general linear model was used to compare treatment time for the first and last 30 patients of the study within the GBP symptom group, controlling for workflow and the workflow-group (first or last) interaction.
The effect of whether a patient had a blood gas analysis and if symptom group had an effect on the treatment time, controlling for the above covariates, was determined by a general linear model. Data analysis was carried out using SAS (version 9.4 for Windows; SAS Institute, Cary, NC). The 5% significance level was used throughout.
Results
Enrollment of 1,134 patients took place between February 13, 2017, and June 29, 2017. Figure 1 summarizes the distribution of patients between the four symptom groups. All workflow groups had a minimum of 24 patients per workflow per symptom group except the psychiatric group. Interim analysis showed that the outcomes for the psychiatric group were very different from the other symptom groups. For that reason, only the control, i-STAT, and i-STAT + CBC workflows were enrolled in this subgroup until completion. The total sample population was therefore 1,044 patients. Ninety patients were excluded due to being underage, missing data collection sheets, or retrospective consent not obtained.
Patient Characteristics
A comparison of patient characteristics based on workflow allocation is tabulated in ❚Table 1❚.
Treatment Times
The treatment time for the psychiatric group (22 minutes; interquartile range [IQR], 17-29) was significantly shorter compared with the other three symptom groups: abdominal pain, 44 minutes (IQR, 36-54; P < .0001); chest pain, 42 minutes (IQR, 34-51; P < .0001); and GBP/ GBW, 38 minutes (IQR, 31-47; P = .0002).
❚Figure 2❚ shows the mean treatment times based on the various workflow permutations across all symptom groups.
The treatment time was significantly shorter compared with the control workflow if the patient received an ECG + LODOX (P = .031), any (i-STAT + CBC)-containing workflows (i-STAT + CBC, P = .0001; i-STAT + CBC + ECG, P = .020; i-STAT + CBC + ECG + LODOX, P = .0009; and i-STAT + CBC + LODOX, P = .011), and the i-STAT + LODOX workflows (i-STAT + ECG + LODOX, P = .0001 and i-STAT + LODOX, P = .034).
The treatment time was also significantly longer for ECG alone compared with i-STAT + CBC (P = .028) and i-STAT + ECG + LODOX (P = .021), as well as being significantly longer for LODOX alone compared with i-STAT + CBC (P = .024) and i-STAT + ECG + LODOX (P = .017).
Treatment Time Saving
❚Table 2❚ demonstrates the number of patients who could be treated in less than 1 hour and those who took more than 2 hours by symptom group and by workflow permutation.
Time Taken for POC Testing
The different permutations of POC tests averaged between 4 and 23 minutes to obtain depending on the test combination. ❚Figure 3❚ displays the mean time taken to perform the tests. Some tests could be performed concurrently while others had to be performed sequentially.
Factors Affecting Arrival Time to Doctor Assessment
Patients waited on average between 57 and 152 minutes to see the doctor after arrival in the ED. The effect of arrival time on waiting time was significant (P = .013), controlling for the other variables in the model. Post hoc tests showed that the estimated time from patient arrival to doctor assessment was significantly shorter if the patient arrived between 7 am and 11 am compared with later in the day, but there were no significant differences in waiting times between the different workflows.
Effect of Discharge vs Admission
There were no significant differences in treatment time between patients who were ultimately admitted or discharged within particular workflows or between admission and discharge within particular symptom groups (P = .091).
Assessment for Consistency
There was no significant difference in treatment times between patients who were enrolled at the beginning of the study compared with those who were enrolled at the end.
Comparison Between Patients Who Had a Blood Gas Analysis Performed by the Doctor on the ED Blood Gas Analyzers vs Those Assigned to an Equivalent i-STATContaining Workflow
The association between ED blood gas analysis and treatment time was significant (P = .002). The treatment time was significantly longer for those patients who had a blood gas (BG) analysis (49 minutes; 95% confidence interval [CI], 34-70) than for those who did not (23 minutes; 95% CI, 15-34).
For each pair of workflows except BG + ECG vs i-STAT + ECG (which was only marginally significant), the treatment time was significantly longer for all workflows with a BG than for the corresponding workflows with i-STAT ❚Figure 4❚.
Costs of Investigations
Costs for the individual investigations are listed in ❚Table 3❚. The ECG costs were the same for both the control and intervention groups. POC equivalent tests cost US$2.54 more per patient than standard control investigations.
Discussion
It has been said that "time heals all wounds," but in the ED, we do not have the privilege of an endless amount of it. Not only do we have to deliver time-critical interventions but we also need to deal with the consequences of patient overcrowding. This is the first study to have assessed the impact of upfront POC testing on treatment times. It is also the first study to have included LODOX as a POC investigation. Since previous studies have not evaluated the utility of POC in this way, it has limited our ability to compare our findings with those of other studies.
Patient Characteristics
In this randomized, controlled trial, the beneficial effects of early POC testing were proven in three common medical patient symptoms groups: abdominal pain, chest pain, and generalized body pain/weakness. As the psychiatric patients who sought treatment from the ED were mostly triaged orange (ie, were generally seen within 10 minutes of arrival the ED), there was no extra benefit in adding early POC testing to their workup pathway.
Treatment Times and Treatment Time Saving
There was statistically and clinically significant time saving in all the symptom groups if the patients had ECG + LODOX, any (i-STAT + CBC)-containing workflows, or any of the four i-STAT + LODOX workflows (20) applied. Conversely, although i-STAT alone and the i-STAT + ECG groups tended toward time saving clinically (ie, exceeding the stipulated outcome measure of a 20% reduction in time compared with the control workflow), they did not show a statistically significant amount of time saved overall. In a previous study of a cohort of patients with chest pain who completed a full battery of standing order tests prior to doctor evaluation, Hwang et al 13 showed a similar statistically significant treatment time decrease of 26 minutes (16.9% reduction compared with control).
In general, it is considered that two-thirds of a patient's entire length of stay in the ED is related to waiting for special investigation results such as blood tests, ECGs, and radiographs.
14 If these tests, with their respective results, could be obtained prior to the doctor's initial evaluation of the patient without extending the patient's total time in the ED, then a substantial amount of time could be saved.
Not only does POC testing have the potential to decrease the therapeutic turnaround or so-called veinto-brain time (ie, the time from ordering the test to the doctor being aware of the result), but it also ensures that the doctor remains focused on the clinical decision that the results are meant to support. 15, 16 Furthermore, once the doctor loses contact with a patient who gets sent for investigations, the delay to awareness of the results being ready can be magnified by the myriad distractions and interruptions present within the ED and other critical care settings.
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Blood Tests
Thirty percent of discharged patients and 47.2% of patients overall seeking treatment from the ED require laboratory tests. 14, 18 Laboratory testing can be the "rate-limiting step for many patients in the ED." 6, 19 In an ED operational simulation study, throughput correlated directly with laboratory result turnaround time. Gardner et al, 21 who looked at factors influencing patient ED length of stay, demonstrated that any blood test increased length of stay by 35.4 to 40.1 minutes, and Yoon et al 14 demonstrated that laboratory testing added 126 minutes to patient length of stay. In our study, all patients in an i-STAT-containing permutation benefited from a decrease in their treatment time.
ECG
Gardner et al 21 found that ECGs added 4.2 minutes to ED length of stay in patients who were discharged from the ED but saved 2.7 minutes for those patients who were admitted. Our findings tended to the same conclusions where the time saving produced by the provision of an ECG alone did not achieve the primary outcome measure of a 20% reduction in treatment time.
Radiography
X-rays are also time-consuming. 1 Gardner et al 21 showed that length of stay increased by 5 to 15 minutes for any x-ray, and Yoon et al 14 reported that x-rays added 60 minutes in their study. In our study, LODOX alone took only 4.5 minutes on average to perform. Although it did not exceed the 20% reduction in treatment time when used alone, it did contribute to time saving when combined with the other tests.
Standing Orders vs Upfront POC Testing and "Overtesting"
The concept of standing orders is not new. Various tests are currently implemented as per protocol for specific presenting complaints. These orders, however, are actioned only if the ED is full, they have not made use of POC devices, and they have had variable uptake by the nursing staff, resulting in both under-and overtesting. 12, 22 There is no evidence to suggest that standing orders and the ease and availability of POC testing would lead to overtesting. [23] [24] [25] In the randomized controlled trial by Begaz et al, 26 which looked at whether screening and initiating diagnostic studies in the waiting room on patients with abdominal pain reduced time spent in the ED, there was a very small overtesting rate. In a study evaluating standing orders specifically, those patients who received the full gamut of tests had a 16% reduction in their mean treatment times and 98% of the patients who did not receive the standing orders went on to receive similar investigations once they were seen, which nullifies the hypothesis that advance protocolized testing leads to "overtesting."
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Time Taken for Upfront POC Testing
The premise behind upfront POC is that the tests are performed during the "front-end" part of the patient's ED journey (ie, during a "non-value-added period") while the patient is waiting for the doctor. 22 The longest time to get all the POC results in this study was on average 23 minutes, which was much shorter than the average 57 to 152 minutes in which the patient waited to see the doctor. This makes the patient's time economically spent.
Assessment for Consistency
There was no evidence of a Hawthorne-type effect. Treatment times were not significantly different between patients enrolled at the beginning compared with the end of the 4-month study period.
Comparison of Patients Who Had a Blood Gas Performed by the Doctor on the ED Blood Gas Analyzers vs Those Assigned to an Equivalent i-STAT-Containing Workflow
Blood gas analysis is a common, quick POC adjunct used in the ED. Despite its convenience and efficiency, it too caused delays in patient disposition. This may be due to an extra step in cognition required to decide whether the test is required as well as the time taken to perform the test itself and then interpret the results. Alternately, this may be due to the patients being sicker, but the effect of triage category was accounted for in the statistical analysis. The upfront, i-STAT blood tests outperformed blood gas analyzer POC testing with regard to decreasing treatment times.
Barriers to the Adoption of POC Testing in the ED
Although not assessed in this study, various barriers have previously been described regarding the implementation of POC testing in the ED. The main obstacles include quality assurance issues regarding calibration as well as analytical reliability and potential higher costs per test for POC in comparison to centralized laboratory testing. 6, 27 The accuracy of POC tests is now generally considered equivalent to tests performed in a central laboratory. 6, 28 Quality control procedures are specific to each POC device and should be performed as per manufacturer's guidelines. Actual costs from previous studies have been varied, with some reporting increased costs and others showing an overall reduction in costs. 29, 30 Some of the nonfiscal "cost savings" should perhaps be evaluated in future cost-effectiveness studies-decreased patient complaints due to excess waiting, increased staff satisfaction, and fewer patients leaving the ED without being seen.
Utility of POC in the ED
In prior studies, there has been mixed evidence for the utility of POC testing in the ED. However, these have previously only been applied after the patient has interacted with a health care practitioner. 1, 4, [8] [9] [10] This has confounded the ability to demonstrate their usefulness for a variety of reasons. A health care provider (commonly a senior doctor or nurse) was required to make a decision regarding the tests required for each individual patient. This takes staff members out of the "seeing patients" circulation and redirects them, leading to potential increases in time required to ultimately assess the patient.
The tests chosen were also not "complete" (eg, the POC tests used by Lee-Lewandrowski et al 4 only included glucose, urine β-human chorionic gonadotropin, urine dipsticks, creatine kinase MB isoenzyme, and troponin)-that is, more tests were needed to make a patient disposition decision.
In addition, these studies only considered the POC route for blood tests. Laboratory tests are not the only "bottleneck" in the system-radiology and ECG delays can also lead to increased treatment times. 1, 14, 21 POC testing has also only previously been shown to be of benefit in specific groups (eg, acute coronary syndrome, where up to 25% of the ED workload patients require a cardiac marker). 24 This study demonstrated the benefit of POC testing across a variety of common ED patient presentation symptom groups.
Limitations
This study was performed in a single center, making extrapolation of the results to other EDs difficult. While the impact on the treatment time was evaluated, there was no assessment of the effect on patient morbidity and mortality. Although staff were not blinded to which patients received the upfront POC tests as opposed to the control pathway, there was no evidence of a Hawthornetype effect. Times, however, were recorded by the doctors themselves and not an impartial observer, which could have been a potential source of error. Cost comparisons were not a primary outcome measure of this study. The total cost calculation was based on the likelihood that the patients in the control pathway received the same tests as an equivalent patient in the POC intervention pathway. Analysis regarding individual patient requirements for testing was not performed separately-this potentially could have led to overtesting. Previous studies have shown this not to be likely.
Conclusions
As Gandalf in J. R. R. Tolkien's Fellowship of the Ring said, "All we have to decide is what to do with the time that is given us."
In order for the full benefit of POC testing to be realized, its implementation needs to be prior to doctor evaluation, as part of a standardized procedure in the ED. This takes advantage of the fast vein-to-brain time as well as the timeous delivery of other adjunct testing results to decrease treatment time.
